Argenx
ARGX
#408
Rank
NZ$106.86 B
Marketcap
NZ$1,718
Share price
-2.52%
Change (1 day)
32.59%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

P/S ratio for Argenx (ARGX)

P/S ratio as of September 2026 (TTM): 13.4

According to Argenx 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 8.55. At the end of 2026 the company had a P/S ratio of 9.21.

P/S ratio history for Argenx from 2022 to 2021

PS ratio at the end of each year

Year P/S ratio Change
20269.21-26.91%
202512.6-26.34%
202417.1-7.07%
202318.4-63.94%
202251.0-17.8%
202162.1
201978.6-34.76%
2018120201.52%
201739.9
201425.2